Merit Medical (MMSI) is a Top-Ranked Momentum Stock: Should You Buy?

Merit Medical (MMSI) is highlighted as a compelling stock, particularly for momentum investors, despite its Zacks #3 (Hold) rank. The company exhibits strong underlying metrics, including an 'A' VGM Score and 'B' Momentum Style Score, alongside a 2.6% share price increase over the past four weeks. Analyst sentiment is positive, with six recent upward revisions to fiscal 2025 earnings estimates, raising the consensus to $3.60 per share, and an average earnings surprise of 12.9%, suggesting MMSI warrants attention for its potential.

Analysis

Merit Medical Systems (MMSI) presents a compelling case based on underlying momentum and fundamental signals, despite its official Zacks #3 (Hold) rating. The stock's positive attributes are highlighted by a top-tier 'A' VGM Score and a 'B' Momentum Style Score, supported by a tangible 2.6% increase in its share price over the past four weeks. Critically, forward-looking sentiment from analysts appears strong, with six upward earnings estimate revisions for fiscal 2025 over the last 60 days. This has lifted the Zacks Consensus Estimate for 2025 by $0.25 to $3.60 per share. The company's track record of operational execution is further evidenced by an average positive earnings surprise of 12.9%, suggesting a consistent ability to exceed market expectations. The combination of upward estimate revisions and strong quant-style scores indicates fundamental strength that may not yet be fully reflected in its neutral analyst rating.

Key Decisions for Investors

• Investors with a momentum-driven strategy should consider MMSI, given its strong 'B' Momentum Score and recent positive price action, but should validate the trend with further technical analysis.
• Fundamental investors should look beyond the neutral 'Hold' rating and focus on the positive leading indicators, such as the six upward analyst revisions for FY2025 earnings, which suggest potential for future outperformance.
• Given the disconnect between the 'Hold' rating and the bullish underlying metrics, it is prudent to monitor for any change in the Zacks Rank or a slowdown in earnings estimate momentum, which could signal a shift in the investment thesis.